Thromboelastometry and Thrombelastography Analysis under Normal Physiological Conditions - Systematic Review. by Adler, Marcel et al.
Fax +49 761 4 52 07 14
Information@Karger.com
www.karger.com
Accessible online at: 
www.karger.com/tmh
Original Article
Transfus Med Hemother 2017;44:78–83
DOI: 10.1159/000464297
Thromboelastometry and Thrombelastography  
Analysis under Normal Physiological Conditions –  
Systematic Review
Marcel Adler a  Sandra Ivic b  Nicolas S. Bodmer b  Hugo ten Cate c  Lucas M. Bachmann b   
Walter A. Wuillemin d  Michael Nagler a,d 
a Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, and Department of Clinical  
 Research, University of Bern, Bern, Switzerland;  
b medignition Inc, Research Consultants, Zurich, Switzerland;  
c Laboratory of Clinical Thrombosis and Hemostasis, and Cardiovascular Research Institute, Maastricht University Medical Center,  
 Maastricht, The Netherlands;  
d Division of Hematology and Central Hematology Laboratory, Luzerner Kantonsspital, University of Bern, Lucerne, Switzerland
gen; clotting time INTEM vs. activated partial thrombo-
plastin time). Conclusions: Studies assessing the rela-
tionship between thromboelastometry or thromboelas-
tography analyses and conventional parameters of he-
mostasis in healthy subjects remains scarce, and 
correlations are limited. Further research is needed to 
understand the physiology of thromboelastometry and 
thromboelastography parameters.
© 2017 S. Karger GmbH, Freiburg
Introduction
Back in 1978, Loop and Lusted [1] proposed the first phased 
evaluation of new medical tests. To date, after the publication of at 
least 18 additional recommendations, (reviewed in [2]) there is a 
broad consensus that first evaluations should address parameters 
of technical efficacy such as minimal detection level, circadian fluc-
tuation, reproducibility, and correlation with established tests in 
healthy volunteers in order to understand the physiology of the 
analyzed parameters. It has been recognized that sophisticated and 
expensive tests that are disseminated without suitable evaluations 
can subsequently be found to have marginal clinical value and eco-
nomic benefit. Well known examples include the carcinoembry-
onic antigen test in the diagnosis of colon cancer [3], iodine-
125-labeled fibrinogen scans in the diagnosis of deep venous 
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Summary
Background: Studies investigating thromboelastometry 
or thrombelastography analyses in a physiological con-
text are scattered and not easy to access. Objective: To 
systematically retrieve and describe published reports 
studying healthy subjects and targeting at the correla-
tion of ROTEM® and TEG® measurements with conven-
tional parameters of hemostasis. Methods: Systematic 
Review: Papers were searched in Medline, Scopus and 
the Science Citation Index database. Reference lists of 
included studies and of reviews were screened. To be in-
cluded papers had to report ROTEM or TEG data on 
healthy subjects. Two reviewers screened papers for in-
clusion, read full texts of potentially relevant papers, and 
extracted data of included papers. Results: Searches 
identified 1,721 records of which 1,713 were either ex-
cluded immediately or after reading the full text. The re-
maining 8 studies enrolled 632 subjects. The association 
of conventional parameters of hemostasis with ROTEM 
and with TEG was investigated in one and two studies, 
respectively. Overall correlation was limited and ranged 
from 0.0 to 0.40 (total thrombus generation vs. fibrino-
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thrombi [4], or rapid magnetic resonance imaging in the manage-
ment of patients with low back pain [5].
Thromboelastometry (ROTEM®) and thrombelastography 
(TEG®) analysis, two methods evaluating hemostasis, are increas-
ingly used in clinical practice, based on the anticipation that they 
improve the management of acute bleeding [6, 7]. Several possible 
advantages over conventional laboratory parameters promote their 
use in emergency units and operating rooms. The analyzer is easy 
to use, and tests are readily available. Results are displayed graphi-
cally, allowing an intuitive interpretation [8]. Furthermore, tests 
claim to provide global information on all aspects of hemostasis, 
including fibrinogen level, platelet function, coagulation cascade, 
cross-linking of fibrin, and fibrinolysis. In addition, whereas the 
therapeutic consequences of results obtained with conventional pa-
rameters often remains uncertain, thromboelastometry/thrombo-
elastography results suggest specific interventions to enhance hemo-
stasis immediately [9]. Several studies explored their role in the 
detection of coagulopathies and changes in bleeding management 
as well as in the perioperative setting [10–14]. However, despite a 
vast amount of investigations, the clinical value of these methods 
has been challenged repeatedly [15–19]. It has been argued that the 
lack of rigorous examinations assessing the correlation of throm-
boelastometry and thromboelastography measurements with con-
ventional parameters of hemostasis jeopardizes its clinical inter-
pretation and usefulness [8, 20, 21]. 
To the best of our knowledge, however, there is no systematic 
review assessing the available evidence on thromboelastometry and 
thromboelastography examinations under physiological conditions 
in healthy volunteers. We therefore set out to systematically search, 
describe and inventory published reports on ROTEM and TEG 
data in healthy subjects, targeting at the correlation of thrombo-
elastometry and thromboelastography measurements with conven-
tional parameters of hemostasis. 
Material and Methods
The present systematic reviews was done according to the PRISMA state-
ment [22]. 
Search Strategy
To identify papers investigating correlations of ROTEM and TEG measure-
ments with conventional parameters of hemostasis under physiological condi-
tions, we searched (PRE-)MEDLINE (PubMed interface) using a search string 
including the two Medical Subject Headings (MeSH) ‘Thrombelastography/
methods’[Mesh], ‘Blood Coagulation Tests’[Mesh] and the free text terms 
thromboelastography, thromboelastometry, ROTEM, and TEG. SCOPUS was 
searched using the following algorithm: TITLE-ABS-KEY(thromboelastography 
OR thromboelastometry)) AND (valid*) AND (LIMIT-TO(DOCTYPE, ‘ar’)) 
AND (LIMIT-TO(SUBJAREA, ‘MEDI’)). We also searched the Web of Science 
database entering 4 seminal papers [8, 23–25] and checked their citations for 
potentially relevant papers. Searches were complemented checking reference 
lists of included studies and of a recently published Cochrane review [15]. Elec-
tronic searches were done from inception to November 2016. 
Selection Criteria for Inclusion
To be included a paper had to use whole blood or citrated blood obtained 
from healthy volunteers and had to assess either ROTEM or TEG. Additional 
criteria had to be fulfilled for inclusion of correlation studies: ROTEM and TEG 
data in combination with at least one established parameter of hemostasis such 
as activated partial thromboplastin time (aPTT), prothrombin time (PT), plate-
let count (PLT), fibrinogen level, or d-dimers. 
Exclusion Criteria
We excluded papers assessing trauma patients, patients undergoing cardiac 
surgery, and other patients with severe illness as well as studies including preg-
nant women, children, or patients with sepsis if the study did not include any 
kind of control arm with healthy subjects. 
Head-to-head comparisons between ROTEM and TEG were also excluded, 
if they were assessed in absence of an established hemostasis method. 
Selection Process and Data Abstraction
In the case of multiple publications on the same participants, the most 
complete report was chosen for each study. We extracted data in duplicate, 
and a third reviewer resolved any discrepancies if the two reviewers disagreed. 
Of each study we extracted participants’ age, number of female participants, 
the total number of included subjects, the device employed (ROTEM, TEG), 
and the hemostasis parameter assessed. In case of TEG studies these were re-
action time (R time), time to maximum clot formation (K time), α angle, MA 
(maximal amplitude), SEMS (shear elastic modulus strength), CI (coagulation 
index), MTG (maximal thrombus generation), TMG (time to maximal throm-
bus generation), and TTG (total thrombus generation). In the ROTEM studies 
CT (clotting time), CFT (clot formation time), alpha angle, and MCF (maxi-
mum clot firmness) for both INTEM and EXTEM assay were recorded. Fi-
nally, we also extracted which of the established methods was used as the 
comparator test and what type of correlation or concordance parameters was 
used.
Thromboelastometry/Thromboelastography Analysis
The analytical principle of thromboelastometry and thromboelastography 
analysis is discussed in detail elsewhere [13, 20, 26–28]. In brief, the viscoelastic 
properties of a forming clot are assessed by recording the oscillations of a pin or 
a cup containing a citrated whole blood sample. Different aspects of clot forma-
tion are represented as parameters of the analysis. For example, the time from 
addition of the reagent until start of clot formation is denoted as CT in case of 
ROTEM, and R time in case of TEG; the clot strength is reported as MCF, or 
MA. Parameters are measured after addition of different activators. By analogy 
with PT, tissue factor reagent is added in case of EXTEM (ROTEM) and Rapid-
TEG. Comparable to the aPTT, contact phase activators are added in case of 
INTEM (ROTEM) or standard TEG. 
Results
Selection Process
Searches retrieved 1,721 records of which 1,588 had to be ex-
cluded after screening title or abstract. Full texts of 133 articles 
were examined for inclusion. Of these, 125 articles fulfilled at least 
one exclusion criterion leaving 8 articles for detailed examination 
[24, 29–35]. The selection process is described in figure 1. 
Included Studies
Thromboelastometry or thromboelastography measurements 
in healthy volunteers have been performed in 8 studies, enrolling 
632 subjects (table 1) [24, 29–35]. Five studies reported thromboe-
lastometry/thromboelastography results but did not investigate 
correlations with conventional parameters of hemostasis [24, 29, 
30, 34, 35]. Lang and colleagues [24] conducted a multicenter 
study to establish reference values for ROTEM thromboelastome-
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try. 262 individuals were included in five centers in Germany, 
Austria, and France. Even though considerable variation between 
centers existed, ‘orientating reference ranges’ were calculated for 
INTEM, EXTEM, and FIBTEM parameters (CT, CFT, α angle, 
A10, A20, A30, MCF, CLI30, and ML). Tripodi and co-workers 
[35] conducted ROTEM measurements in 58 healthy volunteers 
to establish reference ranges for an observation study in cirrhosis 
patients. However, results were not reported, and no correlation 
studies have been done. 20 healthy women were studied using 
ROTEM in an investigation by Huissoud and colleagues [30], 
serving as a control for thromboelastometry patterns in preg-
nancy. Median values and inter-quartile ranges of EXTEM, 
INTEM, FIBTEM, and APTEM parameters were reported. TEG 
was conducted in 5 volunteers in a study by Foley et al. [29] aim-
ing to improve the thromboelastography assay, and individual 
measurements were reported.
Correlation with Conventional Parameters of Hemostasis
Three studies reported the extent of association between throm-
boelastometry/thromboelastography parameters and conventional 
coagulation assays [31–33]. The details are reported in table 2. Two 
studies focused on thromboelastography [32, 33]. In a study enroll-
ing 120 participants (50% female) of 49.5 years on average, Roe-
loffzen and colleagues [33] compared R time with the aPTT, K time 
with the hemoglobin level, aPTT and the fibrinogen level, α angle 
with aPTT and the fibrinogen level, MA with the fibrinogen level, 
SEMS with the fibrinogen level, the CI with aPTT and the fibrino-
gen level, MTG with the fibrinogen level, TMG with aPTT, and the 
TTG with the fibrinogen level. Pearson’s correlation coefficient 
was reported and varied between 0.21 (TMG vs. aPTT) and 0.40 
(TTG vs. fibrinogen level). Rivard and co-workers [32] studied the 
association between a TEG parameter used as surrogate for TTG 
with thrombin generation as measured using thrombin/antithrom-
bin complexes (TAT) in 4 volunteers. A correlation coefficient of 
0.85 was determined from a linear regression and a correlation co-
efficient of 0.94 from a linear regression using the ln of TAT. 
Associations between thromboelastometry parameters and con-
ventional parameters of hemostasis were investigated in one study 
only [31]. Kim and co-workers [31] correlated CT, CFT, α angle, 
CFR, and MCF with PT as well as aPTT. No significant correlation 
was found between any EXTEM or INTEM parameters and PT. 
For INTEM, the CT value was significantly correlated with aPTT 
only (r = 0.41). 
Discussion
Main Findings
Using comprehensive retrieval methods, our systematic review 
only found few studies assessing thromboelastometry as well as 
thromboelastography and correlations thereof with established pa-
rameters of hemostasis in healthy volunteers. The studies revealed 
only a weak correlation. 
Findings in Context
There are several studies investigating the relationship of 
thromboelastometry or thromboelastography in animals, e.g., 
Fig. 1. Study flow.
Table 1. Characteristics of identified evaluation studies in healthy volunteers
Author, year Mean age (SD),  
years
Age range,  
years
Female, n (%) Total (n) Device Correlation/concordance
Lang et al., 2005 [24] 45.4 (17.6);  
43.1 (15.9);  
38.8 (14.4)
– 161 (61.5%) 262 ROTEM –
Rivard et al., 2005 [32] – –   2 (50%)   4 TEG linear/non-linear regression
Tripodi et al., 2009 [35] 20–60  28 (48%)  58 ROTEM –
Huissoud et al., 2009 [30] 30 (median) 26–33  20 (100%)  20 ROTEM –
Scarpelini et al., 2009 [34] 36.8 (11.2) –  40 (34%) 118 TEG –
Roeloffzen et al., 2010 [33] 49.5 (25.5) 19–87  60 (50%) 120 TEG Pearson’s correlation coefficients
Foley et al., 2012 [29] – 29–32   0 (0%)   5 TEG –
Kim et al., 2013 [31] 44 22–71  19 (42%)  45 ROTEM Pearson’s correlation / linear regression
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Mauch et al. [36]. In this study the intrarater and interrater validity 
of the ROTEM data was analyzed with blood from healthy pigs. 
Another prospective study compared the coagulation profiles of 
healthy foals using standard techniques (PT, aPTT, fibrinogen con-
centration, and antithrombin) with the TEG analyzer [37]. The va-
lidity of the ROTEM and TEG was verified through comparison 
with standard methods in the context of specific circumstances, as 
for example orthotropic liver transplantation [38–40], during aor-
tic surgery [12, 41, 42], or in trauma patients [18, 43, 44]. We also 
found a few trials reporting on head-to-head comparisons between 
ROTEM and TEG [21, 45, 46]. Although these approaches also 
yield valuable information, we think that they do not make com-
parisons with standardized methods in healthy subjects 
superfluous. 
Strength and Limitations
We applied up-to-date and rigorous systematic review methods 
to retrieve and assess the available evidence. In view of the risk that 
potentially relevant studies could be missed due to ambiguous in-
dexing in the various databases, we applied an over-inclusive ap-
proach. These sensitive searches retrieved over 1,700 records. 
Screening for inclusion was made in duplicate to reduce the risk to 
miss relevant papers. We expected to find a reasonable number of 
studies that would allow us to provide quantitative summaries of 
various comparisons. Moreover, out of the many available, we 
hoped to depict those parameters from thromboelastometry and 
thrombelastography that would be most suited for investigations in 
various clinical settings such as acute bleeding, applications in 
emergency rooms, and for treatment of patients with specific he-
mostatic deficiencies. Despite our motivation, the current evidence 
base impeded us from generating meaningful summaries for fur-
ther research and clinical practice. 
Implications for Clinical Practice
The small number of studies examining thromboelastometry or 
thromboelastrography in a cohort of healthy volunteers and sys-
tematically comparing the so obtained findings to conventional as-
says of hemostasis is remarkable. One may argue that the clinical 
value of established coagulation parameters is limited as well. It is 
true that results of coagulation parameters such as PT not directly 
prompt any specific treatment. Nevertheless, they are still impor-
tant biomarkers for the detection of coagulopathies in the setting of 
acute bleeding [47–49].
Implications for Research
Following existing guidelines of test evaluation (reviewed and 
discussed in [2]), we propose that further research should first in-
vestigate the distribution of normal values of ROTEM and TEG 
parameters in reasonably sized studies enrolling healthy subjects. 
Second, distributions should be assessed in groups of patients with 
a specific illness and compared to distributions of healthy subjects. 
In a third step, assessing test performance characteristics such as 
sensitivity and specificity should be performed, taking contextual 
clinical information into account. Fourth, studies should deter-
mine the added value of thromboelastometry/thromboelastogra-
phy in context of other clinical information about the patients’ 
state that is available prior testing. Finally, decision-analytic mod-
els should be performed determining the optimal areas for clinical 
use, taking clinical outcomes into account. 
Conclusions
Studies assessing the relationship between thromboelastometry 
or thromboelastography analyses and parameters of hemostasis in 
healthy subjects remains scarce. From a hemostaseologic stand-
point, further physiologic research is needed to elucidate the sig-
nificance of thromboelastometry and thrombelastography for clin-
ical practice and research.
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